| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1650191A1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same |
| 04/26/2006 | EP1650189A1 Benzylamine derivative |
| 04/26/2006 | EP1649856A2 Use of pimecrolimus for selective immunomodulation |
| 04/26/2006 | EP1648902A1 Substituted furochromenes, preparation thereof and their antiinflammatory action |
| 04/26/2006 | EP1648901A1 Substituted furochromene compounds of antiinflammatory action |
| 04/26/2006 | EP1648885A1 Novel compounds |
| 04/26/2006 | EP1648855A2 Levalbuterol hydrochloride polymorph a |
| 04/26/2006 | EP1648476A1 Mouth and/or throat wash |
| 04/26/2006 | EP1572622B1 use of levalbuterol L-tartrate in the production of a metered dose inhaler |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1409485B1 Immunomodulating compounds |
| 04/26/2006 | EP1361894B1 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke acting as a health protecting agent during smoking |
| 04/26/2006 | EP1309592B1 Substituted pyrazoles |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1109553B1 Use of cyclooxygenase-2 inhibitors for the treatment of inflammatory diseases of the head and neck |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1763209A Comprehensive utilization process for gingko episperm |
| 04/26/2006 | CN1763097A Polypeptide variants with altered effector function |
| 04/26/2006 | CN1763075A Solasodine hydrobromate and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763074A Solasodine hydrofluoric acid salt and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763073A Solasodine hydriodate and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763064A Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 04/26/2006 | CN1763002A Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 04/26/2006 | CN1762493A Process for preparing compound aminophylline tablet |
| 04/26/2006 | CN1762475A Effervescence tablet for wind-cold type cold |
| 04/26/2006 | CN1762465A Rhinitis gel, its preparation method and quality control technology |
| 04/26/2006 | CN1762462A Chinese medicinal formulation for treating children's cold and its preparation method |
| 04/26/2006 | CN1762455A Chinese medicinal formulation for treating infant lung and stomach exuberance heat |
| 04/26/2006 | CN1762431A Giant knotweed pills formula and its preparation method |
| 04/26/2006 | CN1762409A Snakegourd peel lyophilized powder injection and its preparation process |
| 04/26/2006 | CN1762408A Honey suckle pill formula and its preparation method |
| 04/26/2006 | CN1762405A Lindley eupatorium herb pills formula and its preparation method |
| 04/26/2006 | CN1762374A Gypenosides pills formula and its preparation method |
| 04/26/2006 | CN1762357A Oral medicinal formulation of moxifloxacin and its preparation method |
| 04/26/2006 | CN1762348A Formula of bergeninum pills and its preparation method |
| 04/26/2006 | CN1762347A Andrographolide preparation and its production method |
| 04/26/2006 | CN1762334A Medicinal cooling emulsions |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253205C 疫苗 Vaccine |
| 04/26/2006 | CN1253189C Children used effervescence tablet with functions of removing lung heat and dissolving phlegm and its preparation |
| 04/26/2006 | CN1253185C Chinese medicine compound preparation for preventing and inhibiting infectious bacteria and virus and its producing method |
| 04/26/2006 | CN1253184C Medicine composition for treating sphagitis and preparing method thereof |
| 04/26/2006 | CN1253175C Medicinal composition, its preparation method and use |
| 04/26/2006 | CN1253168C Medicinal composition for treating chronic obstructive emphysema and preparation method thereof |
| 04/26/2006 | CN1253162C Medicine for treating nascsinusitis and its preparation method |
| 04/26/2006 | CN1253153C Use of trivalency chromium in preparation of drug against allergic rhinitis |
| 04/25/2006 | US7034692 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 04/25/2006 | US7034176 Aminopropylphosphinic acids |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034111 17867, a novel human aminopeptidase |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034042 Corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7034028 Treatment of inflammatory disorders |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/25/2006 | US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/25/2006 | CA2141039C Surfactant free aerosol formulations containing beclomethasone dipropionate |
| 04/20/2006 | WO2006041019A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 04/20/2006 | WO2006041015A1 Amino alcohol derivative, addition salt thereof and immunosuppressive agent |
| 04/20/2006 | WO2006040666A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | WO2006040645A1 N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma |
| 04/20/2006 | WO2006040103A1 Use of cold menthol receptor modulators for the treatment of respiratory disorders |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2006018708A3 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 04/20/2006 | WO2006018609A3 Anti-inflammatory agents |
| 04/20/2006 | WO2006009755A3 Azaindoles modulating c-kit activity and uses therefor |
| 04/20/2006 | WO2005023255A3 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 04/20/2006 | US20060084685 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 04/20/2006 | US20060084684 Topically applicable pharmaceutical preparation |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084653 Beta-sheet mimetics and composition and methods relating thereto |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083714 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 04/20/2006 | US20060083692 Combination of formoterol and a tiotropium salt |
| 04/20/2006 | CA2584293A1 Crig polypeptide for prevention and treatment of complement-associated disorders |